{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:31:00Z","timestamp":1785879060876,"version":"3.56.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141610","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T18:39:51Z","timestamp":1445971191000},"page":"e0141610","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease"],"prefix":"10.1371","volume":"10","author":[{"given":"Sofia","family":"Esteves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Duarte-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Naia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia","family":"Neves-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia","family":"Teixeira-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabela","family":"Silva-Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1471-4159.2009.06302.x","article-title":"The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies","volume":"110","author":"PO Bauer","year":"2009","journal-title":"J Neurochem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0079-6123(08)64029-7","article-title":"Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions","volume":"117","author":"CA Ross","year":"1998","journal-title":"Prog Brain Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Y Kawaguchi","year":"1994","journal-title":"Nat Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/WCO.0b013e3282f7673d","article-title":"New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease)","volume":"21","author":"U R\u00fcb","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1017\/S0317167100034983","article-title":"The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases","volume":"11","author":"A Barbeau","year":"1984","journal-title":"Can J Neurol Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1212\/WNL.28.7.703","article-title":"Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions","volume":"28","author":"P Coutinho","year":"1978","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1212\/WNL.30.3.319","article-title":"Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorena Portuguese family","volume":"30","author":"L Lima","year":"1980","journal-title":"Neurology"},{"key":"ref8","article-title":"Polyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?","author":"G Hoffner","year":"2014","journal-title":"Mol Neurobiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-010-0717-7","article-title":"Axonal inclusions in spinocerebellar ataxia type 3","volume":"120","author":"K Seidel","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref10","first-page":"272","article-title":"Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3","volume":"25","author":"BO Evert","year":"2006","journal-title":"Clin Neuropathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1750-3639.2006.00022.x","article-title":"Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions","volume":"16","author":"U R\u00fcb","year":"2006","journal-title":"Brain Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/701758","article-title":"From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease","volume":"2014","author":"JJ Weber","year":"2014","journal-title":"BioMed Research International"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?","volume":"64","author":"G Rosenberg","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"E Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.bmcl.2007.06.006","article-title":"Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition","volume":"17","author":"Y Shi","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2009.08.001","article-title":"Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington\u2019s disease","volume":"94","author":"D Z\u00e1dori","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","article-title":"Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice","volume":"86","author":"L-K Tsai","year":"2008","journal-title":"J Mol Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuroscience.2008.06.040","article-title":"Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"155","author":"H-L Feng","year":"2008","journal-title":"Neuroscience"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e54792","DOI":"10.1371\/journal.pone.0054792","article-title":"Sodium valproate alleviates neurodegeneration in SCA3\/MJD via suppressing apoptosis and rescuing the hypoacetylation levels of histone H3 and H4","volume":"8","author":"J Yi","year":"2013","journal-title":"PLoS ONE"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijdevneu.2014.07.004","article-title":"Valproic acid attenuates the suppression of acetyl histone H3 and CREB activity in an inducible cell model of Machado-Joseph disease","volume":"38","author":"XP Lin","year":"2014","journal-title":"Int J Dev Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1093\/hmg\/ddr203","article-title":"Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways","volume":"20","author":"A Teixeira-Castro","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s13311-013-0255-9","article-title":"Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease","volume":"11","author":"A Silva-Fernandes","year":"2014","journal-title":"Neurotherapeutics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4614-8289-5_6","article-title":"The role of the Gadd45 family in the nervous system: a focus on neurodevelopment, neuronal injury, and cognitive neuroepigenetics","volume":"793","author":"FA Sultan","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbamcr.2003.10.013","article-title":"Bcl-2 family regulation of neuronal development and neurodegeneration","volume":"1644","author":"RS Akhtar","year":"2004","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Molecular Cell Research"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.yexcr.2007.02.019","article-title":"Gadd45a, the gene induced by the mood stabilizer valproic acid, regulates neurite outgrowth through JNK and the substrate paxillin in N1E-115 neuroblastoma cells","volume":"313","author":"J Yamauchi","year":"2007","journal-title":"Exp Cell Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1158\/1078-0432.CCR-10-1707","article-title":"Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia","volume":"16","author":"C Xie","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1074\/jbc.272.7.4327","article-title":"Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins","volume":"272","author":"JA Morris","year":"1997","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"JS Steffan","year":"2001","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice","volume":"23","author":"RJ Ferrante","year":"2003","journal-title":"J Neurosci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington\u2019s disease","volume":"100","author":"E Hockly","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nbd.2010.10.019","article-title":"HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3","volume":"41","author":"A-H Chou","year":"2011","journal-title":"Neurobiol Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/13543784.17.2.169","article-title":"Histone deacetylase inhibitors: possible implications for neurodegenerative disorders","volume":"17","author":"E Hahnen","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","article-title":"Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"13","author":"M Minamiyama","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.1139-07.2007","article-title":"Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model","volume":"27","author":"C Rouaux","year":"2007","journal-title":"J Neurosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eplepsyres.2008.04.019","article-title":"Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases?","volume":"81","author":"K Hoffmann","year":"2008","journal-title":"Epilepsy Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.yexcr.2007.02.019","article-title":"Gadd45a, the gene induced by the mood stabilizer valproic acid, regulates neurite outgrowth through JNK and the substrate paxillin in N1E-115 neuroblastoma cells","volume":"313","author":"J Yamauchi","year":"2007","journal-title":"Exp Cell Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.18632\/oncotarget.430","article-title":"A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer","volume":"3","author":"RH Stauber","year":"2012","journal-title":"Oncotarget"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/ijc.24158","article-title":"Valproic acid enhances bosutinib cytotoxicity in colon cancer cells","volume":"124","author":"L Mologni","year":"2009","journal-title":"Int J Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1073\/pnas.262658999","article-title":"An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability","volume":"99","author":"L Tremolizzo","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0317167100021879","article-title":"Weight gain in epileptic patients during treatment with valproic acid: a retrospective study","volume":"24","author":"CL Corman","year":"1997","journal-title":"Can J Neurol Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/0269881108091595","article-title":"Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial","volume":"23","author":"CK Martin","year":"2009","journal-title":"J Psychopharmacol (Oxford)"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/j.1467-789X.2010.00800.x","article-title":"Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications","volume":"12","author":"A Verrotti","year":"2011","journal-title":"Obes Rev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2990.2006.00772.x","article-title":"Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7","volume":"32","author":"U R\u00fcb","year":"2006","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/brain\/awf208","article-title":"Spinocerebellar ataxia type 3 (Machado-Joseph disease): severe destruction of the lateral reticular nucleus","volume":"125","author":"U R\u00fcb","year":"2002","journal-title":"Brain"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"20915","DOI":"10.1074\/jbc.M212328200","article-title":"Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation","volume":"278","author":"RK Reddy","year":"2003","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"21751","DOI":"10.1074\/jbc.272.35.21751","article-title":"Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells","volume":"272","author":"H Liu","year":"1997","journal-title":"J Biol Chem"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7412.1000128","article-title":"The Molecular Chaperone GRP78\/BiP as a Therapeutic Target for Neurodegenerative Disorders: A Mini Review","volume":"4","author":"MS Gorbatyuk","year":"2013","journal-title":"J Genet Syndr Gene Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/256404","article-title":"Crosstalk between Endoplasmic Reticulum Stress and Protein Misfolding in Neurodegenerative Diseases","volume":"2013","author":"CMF Pereira","year":"2013","journal-title":"ISRN Cell Biology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1645\/GE-1331.1","article-title":"Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice","volume":"94","author":"DG Goodwin","year":"2008","journal-title":"J Parasitol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01962705","article-title":"Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals","volume":"14","author":"W L\u00f6scher","year":"1992","journal-title":"Pharm Weekbl Sci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"10471","DOI":"10.1523\/JNEUROSCI.0670-13.2013","article-title":"Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease","volume":"33","author":"LM Valor","year":"2013","journal-title":"J Neurosci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"AG Kazantsev","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0887-8994(02)00505-2","article-title":"Valproic acid-associated weight gain in older children and teens with epilepsy","volume":"28","author":"EC Wirrell","year":"2003","journal-title":"Pediatr Neurol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1345\/aph.1L414","article-title":"Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy","volume":"43","author":"S Grosso","year":"2009","journal-title":"Ann Pharmacother"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.seizure.2007.11.007","article-title":"Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms","volume":"17","author":"J Isoj\u00e4rvi","year":"2008","journal-title":"Seizure"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.reprotox.2011.02.002","article-title":"Hormonal and reproductive disturbances in epileptic male patients: emerging issues","volume":"31","author":"A Verrotti","year":"2011","journal-title":"Reprod Toxicol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jmg.32.9.724","article-title":"Fetal valproate syndrome","volume":"32","author":"J Clayton-Smith","year":"1995","journal-title":"J Med Genet"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-200629010-00001","article-title":"Valproic acid in epilepsy: pregnancy-related issues","volume":"29","author":"P Genton","year":"2006","journal-title":"Drug Saf"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"A Ornoy","year":"2009","journal-title":"Reprod Toxicol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/0023677213516312","article-title":"FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units","volume":"48","author":"Convenor M M\u00e4hler","year":"2014","journal-title":"Lab Anim"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2010.05.021","article-title":"Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products","volume":"40","author":"A Silva-Fernandes","year":"2010","journal-title":"Neurobiol Dis"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s003350010149","article-title":"Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice","volume":"11","author":"JA Rafael","year":"2000","journal-title":"Mamm Genome"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"RJ Carter","year":"1999","journal-title":"J Neurosci"},{"key":"ref64","author":"KBJ Franklin","year":"2013"},{"key":"ref65","author":"JH Zar","year":"1999"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T01:17:15Z","timestamp":1567300635000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141610"}},"subtitle":[],"editor":[{"given":"Pedro","family":"Gonzalez-Alegre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":65,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141610","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]}}}